More News – Page 16
-
NewsMicrobes: atmospheric methane increase during pandemic due primarily to wetland flooding
A new analysis of satellite data finds that the record surge in atmospheric methane emissions from 2020 to 2022 was driven by increased inundation and water storage in wetlands, combined with a slight decrease in atmospheric hydroxide (OH).
-
NewsStudy finds outbreak detection under-resourced in Asia
A two-year assessment provides critical insights and recommendations for strengthening genomic sequencing for infectious disease surveillance in 13 South and Southeast Asian countries.
-
NewsNew method sheds light on early cellular and metabolic evolution
Researchers have developed a pioneering method of analysis to investigate microfossils, by fixing them onto a specially coated glass slide (ITO-glass), allowing for integrated observations using both optical and electron microscopy.
-
NewsGraphene spike mat and fridge magnet tech team up against antibiotic resistance
Researchers have deployed the bactericidal properties of graphene by using the same technology found in an ordinary fridge magnet, resulting in an ultra-thin acupuncture-like surface that can act as a coating on catheters and implants.
-
NewsHuman urine could be used as eco-friendly crop fertilizer
Bacterial communities in soil are as resilient to human urine as synthetic fertilisers – making recycling the bodily fluid as a fertiliser for agricultural crops a viable proposition, according to a new study.
-
NewsBetter together: Gut microbiome communities’ resilience to drugs
Many human medications can directly inhibit the growth and alter the function of the bacteria that constitute our gut microbiome. EMBL Heidelberg researchers have now discovered that this effect is reduced when bacteria form communities.
-
NewsCan a drug-free nasal spray protect against deadly respiratory infections?
A novel nasal spray for preventing respiratory infections works by forming a protective coating on the nasal cavity, which captures airborne respiratory droplets and acts as a physical barrier against viruses and bacteria, while effectively neutralizing them.
-
News‘Invisible forest’ of algae thrives as ocean warms
An ‘invisible forest’ of phytoplankton is thriving in part of our warming ocean, new research shows. The study examined phytoplankton at the ocean surface and the ‘subsurface’ – a distinct layer of water beneath – to see how climate variability is affecting them.
-
NewsEuropean capacity for antibiotic R&D requires long-term funding
The AMR Accelerator projects have called for long-term investments, stressing the need to preserve the European capacity for antibiotic R&D by sustaining the assets, expertise, and research infrastructures required to develop new treatments for drug-resistant infections.
-
NewsFeeding coral reefs can aid their recovery from bleaching events
Coral reefs will continue to experience severe heat stress as rising temperatures cause the oceans to become unbearably hot – but a new study shows that altering their feeding habits could allow local populations to avoid total extinction.
-
NewsDeeper corals may help shallow reefs recover in the Florida keys
Using the blushing coral star (Stephanocoenia intersepta), found throughout the Western Atlantic, researchers have investigated how coral populations at different depths and locations may be related or ‘connected’ to each other.
-
NewsDietary fibre powers the multivitamin factory in your gut
A study has uncovered how dietary fibres can enhance the availability of gut microbiome-produced B vitamins to the host to impact immune health.
-
NewsStudy reveals link between microbiome and aggression
A new study has unveiled significant evidence connecting the gut microbiome to aggressive behavior in mice. The research explores how disruptions in the microbiome, particularly due to antibiotic use in early life, can lead to increased aggression.
-
NewsEradivir closes $10.25M Series A funding round for next stage of influenza therapeutic trials
Eradivir, a preclinical biotech company that develops antiviral therapeutics, has completed a $10.25 million Series A funding round which will be used to conduct a Phase 2a challenge study of its EV25 influenza treatment.
-
NewsBacteria ‘doing their job’, as nitrogen fertilizer for soybeans offers limited yield benefits
Researchers tested whether modern high-yielding soybeans benefit from nitrogen fertilizer, with results suggesting additions are largely unnecessary.
-
NewsMedical device could diagnose respiratory infections with breath
A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath.
-
NewsFleming Initiative raises first £100m in the global fight against AMR
Three new partners have pledged additional funding and resources to the Fleming Initiative’s global effort to combat antimicrobial resistance (AMR), as leading medical expert Professor Lord Ara Darzi calls for tighter restrictions on the use of antibiotics.
-
NewsFruit-only diet improves bats’ immune response to viruses
Fruit bats generate more diverse antibodies than mice, but overall have a weaker antibody response, according to a new study.
-
NewsScientist studying parasite-derived vesicles in babesia virulence and vaccine development
Fatah Kashanchi, Professor of Virology at George Mason University, has received funding for the study: ’Parasite-Derived Vesicles in Babesia virulence and Vaccine Development’.
-
NewsStudy charts spectrum of febrile rash illness in China from 2009 to 2021
A new study monitors the spectrum of viral pathogens involved in febrile rash illness (FRI) and their epidemiology.
